Lincoln Pharmaceuticals sees 31% profit growth in Q1 FY27
Lincoln Pharmaceuticals announced its total income for the first quarter of FY27 reached ₹201.55 crore, marking a 19.02% increase compared to the previous year. The company's EBITDA climbed by 32.29% to hit ₹51.70 crore. Meanwhile, consolidated net profit grew by 30.90%, rising from ₹27.68 crore to ₹36.23 crore. Looking ahead, the firm aims to achieve ₹1,000 crore in revenue within the next three years and currently maintains an export presence in over 60 nations.
by shortkt.com✓